Skip to main content
. 2020 Jul 9;9(7):2170. doi: 10.3390/jcm9072170

Figure 4.

Figure 4

Representative images of outcome at the gluteal region in case #1; a female patient, aged 52 years with onset of psoriasis at 47 years of age. At baseline, PASI was 44.4 and VAS pain was 80. After 12 weeks with guselkumab (induction phase: 100 mg subcutaneously at weeks 0 and 4, and a maintenance dose every 8 weeks thereafter), PASI decreased to 3 and VAS pain was 30.